Search Results

There are 7185032 results for: content related to: LRRK2 G2019S founder haplotype in the Chinese population

  1. You have full text access to this OnlineOpen article
    Cellular processes associated with LRRK2 function and dysfunction

    The FEBS Journal

    Volume 282, Issue 15, August 2015, Pages: 2806–2826, Rebecca Wallings, Claudia Manzoni and Rina Bandopadhyay

    Version of Record online : 9 MAY 2015, DOI: 10.1111/febs.13305

  2. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2

    Journal of Neuroscience Research

    Volume 93, Issue 10, October 2015, Pages: 1567–1580, Matthew Hamm, Rachel Bailey, Gerry Shaw, Shu-Hui Yen, Jada Lewis and Benoit I. Giasson

    Version of Record online : 30 JUN 2015, DOI: 10.1002/jnr.23614

  3. Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)

    Human Mutation

    Volume 35, Issue 4, April 2014, Pages: 395–412, Ryan D. Mills, Terrence D. Mulhern, Fei Liu, Janetta G. Culvenor and Heung-Chin Cheng

    Version of Record online : 24 FEB 2014, DOI: 10.1002/humu.22515

  4. You have full text access to this OnlineOpen article
    Novel recruitment strategy to enrich for LRRK2 mutation carriers

    Molecular Genetics & Genomic Medicine

    Volume 3, Issue 5, September 2015, Pages: 404–412, Tatiana Foroud, Danielle Smith, Jacqueline Jackson, Jennifer Verbrugge, Cheryl Halter, Leah Wetherill, Katherine Sims, Winnie Xin, Vanessa Arnedo, Shirley Lasch, Kenneth Marek and the Parkinson's Progression Markers Initiative

    Version of Record online : 6 MAY 2015, DOI: 10.1002/mgg3.151

  5. You have free access to this content
    LRRK2 pathobiology in Parkinson's disease

    Journal of Neurochemistry

    Volume 131, Issue 5, December 2014, Pages: 554–565, Ian Martin, Jungwoo Wren Kim, Valina L. Dawson and Ted M. Dawson

    Version of Record online : 10 OCT 2014, DOI: 10.1111/jnc.12949

  6. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 889–897, Nicolas Dzamko, Dominic B. Rowe and Glenda M. Halliday

    Version of Record online : 25 FEB 2016, DOI: 10.1002/mds.26529

  7. You have free access to this content
    Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β

    The FEBS Journal

    Volume 281, Issue 1, January 2014, Pages: 3–13, Fumitaka Kawakami, Naoki Shimada, Etsuro Ohta, Go Kagiya, Rei Kawashima, Tatsunori Maekawa, Hiroko Maruyama and Takafumi Ichikawa

    Version of Record online : 28 NOV 2013, DOI: 10.1111/febs.12579

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  9. You have free access to this content
    Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1

    Journal of Neurochemistry

    Volume 128, Issue 4, February 2014, Pages: 561–576, Gregory C. Luerman, Chuong Nguyen, Harry Samaroo, Paula Loos, Hualin Xi, Andres Hurtado-Lorenzo, Elie Needle, G. Stephen Noell, Paul Galatsis, John Dunlop, Kieran F. Geoghegan and Warren D. Hirst

    Version of Record online : 11 NOV 2013, DOI: 10.1111/jnc.12483

  10. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

    Movement Disorders

    Connie Marras, Roy N. Alcalay, Chelsea Caspell-Garcia, Christopher Coffey, Piu Chan, John E. Duda, Maurizio F. Facheris, Rubén Fernández-Santiago, Javier Ruíz-Martínez, Tiago Mestre, Rachel Saunders-Pullman, Claustre Pont-Sunyer, Eduardo Tolosa, Bjorg Waro and the LRRK2 Cohort Consortium

    Version of Record online : 19 APR 2016, DOI: 10.1002/mds.26614

  11. You have free access to this content
    The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition

    Journal of Neurochemistry

    Volume 115, Issue 1, October 2010, Pages: 36–46, Jason P. Covy and Benoit I. Giasson

    Version of Record online : 8 JUL 2010, DOI: 10.1111/j.1471-4159.2010.06894.x

  12. You have free access to this content
    Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 650–658, Jingwen Niu, Mei Yu, Chunyan Wang and Zhiheng Xu

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07809.x

  13. You have free access to this content
    Investigation of leucine-rich repeat kinase 2

    The FEBS Journal

    Volume 276, Issue 2, January 2009, Pages: 466–478, Vasanti S. Anand, Laurie J. Reichling, Kerri Lipinski, Wayne Stochaj, Weili Duan, Kerry Kelleher, Pooja Pungaliya, Eugene L. Brown, Peter H. Reinhart, Richard Somberg, Warren D. Hirst, Steven M. Riddle and Steven P. Braithwaite

    Version of Record online : 8 DEC 2008, DOI: 10.1111/j.1742-4658.2008.06789.x

  14. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

    Movement Disorders

    Volume 26, Issue 8, July 2011, Pages: 1386–1397, Zhenyu Yue and M. Lenard Lachenmayer

    Version of Record online : 29 APR 2011, DOI: 10.1002/mds.23737

  15. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

    Movement Disorders

    Volume 22, Issue 8, 15 June 2007, Pages: 1194–1201, Joaquim J. Ferreira, Leonor Correia Guedes, Mário Miguel Rosa, Miguel Coelho, Marina van Doeselaar, Dorothea Schweiger, Alessio Di Fonzo, Ben A. Oostra, Cristina Sampaio and Vincenzo Bonifati

    Version of Record online : 27 APR 2007, DOI: 10.1002/mds.21525

  16. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1004–1011, David A. Elliott, Woojin S. Kim, Sarsha Gorissen, Glenda M. Halliday and John B.J. Kwok

    Version of Record online : 23 APR 2012, DOI: 10.1002/mds.25005

  17. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease

    Movement Disorders

    Volume 22, Issue 7, 15 May 2007, Pages: 982–989, Yue Huang, Glenda M. Halliday, Himesha Vandebona, George D. Mellick, Frank Mastaglia, Julia Stevens, John Kwok, Michael Garlepp, Peter A. Silburn, Malcolm K. Horne, Katya Kotschet, Alison Venn, Dominic B. Rowe, Justin P. Rubio and Carolyn M. Sue

    Version of Record online : 11 APR 2007, DOI: 10.1002/mds.21477

  18. You have free access to this content
    LRRK2 in Parkinson’s disease: genetic and clinical studies from patients

    The FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6455–6463, Udhaya Kumari and E. K. Tan

    Version of Record online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07344.x

  19. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2536–2541, Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius and Susan B. Bressman

    Version of Record online : 3 SEP 2010, DOI: 10.1002/mds.23314

  20. You have free access to this content
    Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease

    Journal of Neuroscience Research

    Volume 87, Issue 6, 1 May 2009, Pages: 1283–1295, Payal N. Gandhi, Shu G. Chen and Amy L. Wilson-Delfosse

    Version of Record online : 21 NOV 2008, DOI: 10.1002/jnr.21949